Synbio Tech (ROCO:1295) Equity-to-Asset : 0.50 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Synbio Tech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$943.0 Mil. Synbio Tech's Total Assets for the quarter that ended in Dec. 2023 was NT$1,886.2 Mil. Therefore, Synbio Tech's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.50.

The historical rank and industry rank for Synbio Tech's Equity-to-Asset or its related term are showing as below:

ROCO:1295' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5 Med: 0.54 Max: 0.56
Current: 0.5

During the past 4 years, the highest Equity to Asset Ratio of Synbio Tech was 0.56. The lowest was 0.50. And the median was 0.54.

ROCO:1295's Equity-to-Asset is ranked worse than
64.65% of 1556 companies
in the Biotechnology industry
Industry Median: 0.67 vs ROCO:1295: 0.50

Synbio Tech Equity-to-Asset Historical Data

The historical data trend for Synbio Tech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech Equity-to-Asset Chart

Synbio Tech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.55

0.56

0.54

0.50

Synbio Tech Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.56	-	0.54	0.49	0.50

Competitive Comparison of Synbio Tech's Equity-to-Asset

For the Biotechnology subindustry, Synbio Tech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synbio Tech's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synbio Tech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Synbio Tech's Equity-to-Asset falls into.

Synbio Tech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Synbio Tech's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	942.969	/	1886.24
	=	0.50

Synbio Tech's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	942.969	/	1886.24
	=	0.50

Synbio Tech (ROCO:1295) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Synbio Tech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Synbio Tech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Synbio Tech (ROCO:1295) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66,Beiling 6th Road, 821 Road, Luzhu District, Kaohsiung, TWN

Website

https://www.synbiotech.com

Synbio Tech Inc is a company specializing in the research, manufacturing and application development of lactic acid bacteria. They provide lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products , share application development technology, provide excellent service quality, and gain recognition from customers, allowing Shenghe to grow steadily.

Synbio Tech (ROCO:1295) Headlines

No Headlines